ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VAL Valirx Plc

3.30
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Valirx Plc LSE:VAL London Ordinary Share GB00BLH13C52 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.30 3.20 3.40 3.30 3.30 3.30 56,258 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 0 -2.37M -0.0262 -1.26 2.98M
Valirx Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker VAL. The last closing price for Valirx was 3.30p. Over the last year, Valirx shares have traded in a share price range of 3.25p to 14.75p.

Valirx currently has 90,174,156 shares in issue. The market capitalisation of Valirx is £2.98 million. Valirx has a price to earnings ratio (PE ratio) of -1.26.

Valirx Share Discussion Threads

Showing 18651 to 18674 of 29350 messages
Chat Pages: Latest  754  753  752  751  750  749  748  747  746  745  744  743  Older
DateSubjectAuthorDiscuss
25/9/2020
11:55
Just remember SNG
You wouldn’t have time
to buy in it went from
35p to over £2 in a blink!!
ENJOY😉

shares188
25/9/2020
11:50
Were back moving up again now.
412069
25/9/2020
11:32
Depends on results.

Is this an exceptable pause or a bit of nerves re- results?

guss
25/9/2020
11:29
I would not like being out with results due any time!
pennstreet
25/9/2020
09:40
Wrong thread This is the buy Val sell pyc thread !
nico115
25/9/2020
09:34
Worth laying out why this could be huge for PYC and arguably maybe even bigger and better for PYC than for VAL!

1. PYC have a FREE carried interest. We won't have to meet future costs of VAL201 (or VAL overheads) i.e. Trials costs/share dilution of Phase II/Phase III

2. Any VAL success in demonstrating SRC Inhibition approach may mean PYC can sell their SRC Inhibition modelling and simulation skills to other Companies looking to follow similar approach (maybe outside of Prostate Cancer as contract with VAL may have included a non-compete clause)

3. I believe Physiomics deliberately mentioned VAL201 in their August tweet because VAL have already approached them with regards to potentially engaging PYC to do modelling and simulation work on any future Phase II/III trial either for optimal dosing or potential combinations with potential Partner drugs?


Proactive : "ValiRx teams up with Physiomics to accelerate the development of anti-cancer compound"

www.proactiveinvestors.co.uk/companies/news/27661/ValiRx-teams-up-with-Physiomics-to-accelerate-the-development-of-anti-cancer-compound-33038.html

the stigologist
25/9/2020
09:30
No he just Ramps another stock on here as he knows this is the place to be !! Lol
nico115
25/9/2020
09:27
Stigologist , do you own any VAL ?
arab3
25/9/2020
09:12
I'll be switching to EVG, possibly N4P, jury out on PYC at the mo
jusjusjus
25/9/2020
09:09
VAL has risen 200-300% on VAL201 but PYC unchanged so i can see some switching will go on
the stigologist
25/9/2020
09:06
hardly surprising when we started the week @ 24p!
jusjusjus
25/9/2020
09:02
Looks like we have someone drip feeding 30k sells into the MM's at a base price of 60p. Won't rise much above that whilst their line of stock lasts
tburns
25/9/2020
08:45
we'll take a look after results Stig!
jusjusjus
25/9/2020
08:43
PYC gets free access to Upside from VAL201 without any of the downside risk of having to fund expensive Phase II/Phase III trials through dilution or go through the process of seeking larger Companies to fund the trials.
the stigologist
25/9/2020
08:18
Should this share be relabelled Old faithful?
stumbleupon
25/9/2020
08:16
Auction at 64p :-)
tburns
25/9/2020
08:15
And UP she goes!!
tburns
25/9/2020
08:12
Prefer Val to pyc Should be a strong day in lead up to 201 I've top sliced but still bullish
nico115
25/9/2020
08:10
Lots of peeps keen to get in this morning ahead of Mondays results even after a 7 bagger, says it all really. GLA
tburns
25/9/2020
08:08
PYC tweeted about VAL201 in August so i suspect they are already talking about next steps.

PYC could benefit in 3 distinct ways from any VAL201 'success'

1. Licensing income share

2. More modelling work on VAL201 as monotherapy or in combination with other drugs

3. More work from bios/pharmas wanting SRC Inhibitor expertise

Game changer on several fronts

the stigologist
25/9/2020
07:16
Shares188. Probably Monday methinks
carlisle44
24/9/2020
20:53
Onwards and upwards!
Who thinks news tomorrow?
I feel leaving it until the
last day of Sept next week is
slightly unsettling.

shares188
24/9/2020
20:39
There won't be a move 'straight' to licence (believe me as a PYC shareholder I'd love it if we did get a % of licence fee sooner rather than later!) let alone commercial sales

Licence will only occur after they've published data in a peer reviewed journal

Then they'll probably open a data room so any potential partners can have a look at details of patents/data etc

Only then will they likely partner. That could take a year?

Commercial sales may take 5 years post Phase II/III results and then FDA consideration and approval

Remember these things take time

The original modelling and development of this drug occurred in 2011 when VAL and PYC worked together on it

It's taken several years to get thru Preclinical Phase and now Phase I/II

the stigologist
24/9/2020
20:33
Slight change at the end today,
I think news tomorrow.
This has been one hell of a ride,
Can it do a SNG movement which
went from 35p to £2.80😉
In one day...

shares188
Chat Pages: Latest  754  753  752  751  750  749  748  747  746  745  744  743  Older

Your Recent History

Delayed Upgrade Clock